Summary. There are controversial reports in the literature concerning the effects of opioids on superoxide (02) formation in phagocytes, these agents being either inhibitory or stimulatory. We re-examined this issue and compared the effects of the chemotactic peptide, N-formyl-L-methionyl-Lleucyl-L-phenylalanine (fMet-Leu-Phe), phorbol myristatc acetate (PMA), ATP, platelet activating factor (PAF), cytochalasin B (CB) and prostaglandin E1 (PGE1) with those of various opioids on 02 formation in human neutrophils and HL-60 leukemic cells under defined experimental conditions. In the presence of CB, fMet-Leu-Phe and PAF concentration-dependently activated O~ formation in neutrophils with ECs0 values of 20 nM and 100 nM, respectively. In the absence of CB, fMet-Lcu-Phe and PAF were much less effective. PAF synergistically enhanced O~ formation induced by fMet-Leu-Phe. ATP at a concentration of 100 gM and the opioids, methionine enkephalin, fl-endorphin, dynorphin, [D-Ala z, N-Me-Phe 4, GlyS-ol]-enkephalin, [I>Ala2-D-LeuS]-enkephalin and morphine at concentrations between 10 pM to 1 gM did not activate Oz formation. ATP but not//-endorphin potentiated fMet-LeuPhe-induced 02 formation. 02 formation induced by a maximally stimulatory concentration of PMA (100 ng/ml) was enhanced by fMet-Leu-Phe but was unaffected by methionine enkephalin or PGE1. PMA at a non-stimulatory concentration (2 ng/ml) potentiated the effect of fMet-Leu-Phe but did not induce responsiveness to PAF, ATP or /?-endorphin. PGE1 strongly inhibited fMet-Leu-Phe-induced 02 formation, whereas morphine, methionine enkephalin and the opioid antagonist, naloxone, were without effect. In HL-60 cells differentiated with dibutyryl cAMP, fMet-LeuPhe, PAF and ATP but not/~-endorphin activated 02 formation. Our results show that 02 formation is differentially regulated by various classes of intercellular signal molecules and that opioids do not play a role in the regulation of 02 formation. The precise definition of the experimental conditions and control experiments with established modulators of 02 formation are essential to evaluate the role of opioids in the regulation of this effector system.
Introduction
Human neutrophils and differentiated HL-60 leukemic cells possess a NADPH oxidase which catalyzes superoxide (02)
Send offprint requests to R. Seifert at the above address formation. Activation of O2 formation plays a key role in host defense against infections and in the pathogenesis of various diseases such as rheumatoid arthritis, nephritis and myocardial infarction (Rossi 1986; Malech and Gallin 1987) . 02 formation is activated by multiple stimuli such as the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe), platelet activating factor (PAF) and the activator of protein kinase C, 4fl-phorbol 12-myristate 13-acetate (PMA) (Rossi 1986 ). In comparison to fMet-Leu-Phe, PAF is a weak activator of 02 formation and potentiates the effects of chemotactic peptides Baggiolini 1985, 1986 ). In addition, PMA at non-stimulatory concentrations potentiates chemotactic peptide-induced 02 formation, a process called priming (Ohsaka et al. 1988; Raj Tyagi et al. 1988) . Furthermore, ATP via purinoceptors enhances fMet-Leu-Pheinduced Of formation in human neutrophils (Kuhns et al. 1988 ) and per se activates 02 formation in HL-60 cells differentiated with dibutyryl cAMP (dbcAMP) ). Finally, cytochalasin B (CB) enhances the effects of chemotactic peptides (Jesaitis et al. 1986 ). In contrast, activators of adenylyl cyclase such as prostaglandin E~ (PGE1) inhibit stimulated O~ formation (Lad et al. 1985) .
The reports in the literature concerning the effects of opioids on 02 formation are controversial. Neutrophils possess high affinity binding sites for dihydromorphine (Lopker et al. 1980) . Morphine, fl-endorphin, dynorphin and methionine enkephalin have been reported to stimulate 02 formation in human neutrophils and macrophages (Foris et al. 1986; Sharp et al. 1985 Sharp et al. , 1987 Nagy et al. 1988 ). In contrast, Simpkins et al. (1986) did not find a stimulatory effect of methionine enkephalin on Oz formation. On the other hand, morphine, methionine enkephalin and the opioid antagonist, naloxone, have been reported to inhibit fMet-Leu-Pheinduced Of formation (Simpkins et al. 1985 (Simpkins et al. , 1986 . The inhibitory effect ofmethionine enkephalin on 02 formation may be due to its structural similarity with prostaglandins (Simpkins et al. 1986) . Considering the important physiological and pharmacological implications of the possibility that opioid peptides, morphine and opioid antagonists may play a role in the regulation of 02 formation we reinvestigated this issue. In contrast to previous reports we did not find any effect of opioids on O2 formation. Under the experimental conditions employed by us, the results concerning the regulation of this effector system by other intercellular signal molecules are in close agreement with previously published work.
Materials and methods
Materials. PAF (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) was kindly provided by Dr. Santosh Nigam (Abteilung ffir Gyn/ikologische Endokrinologie, Universit/itsklinikum Steglitz, Freie Universit/it Berlin). Methionine enkephalin, fl-endorphin (human sequence), dynorphinl-17,
, CB, PGE~, superoxide dismutase and ferricytochrome C (type III) were obtained from Sigma Chemie (Taufkirchen, FRG). DbcAMP was purchased from Pharma Waldhof (Dfisseldoff, FRG), and ATP was from Boehringer Mannheim (Mannheim, FRG). All cell culture media and FicollHypaque were obtained from Biochrom (Berlin). Morphine hydrochloride was purchased from Merck (Darmstadt, FRG) . Liquemin N 25.000 was from Hoffmann-La Roche (Grenzach-Whylen, FRG). Dextran T 500 was purchased from Pharmacia (Uppsala, Sweden). Stock solutions of PMA (10 mg/ml), FMLP (10 raM), Boc-PLPLP (50 mM) and CB (i mg/ml) were prepared in dimethyl sulfoxide and stored at -20°C. PAF (1 mM) and PGE1 (2.5 raM) were dissolved in absolute ethanol and stored at -20 ° C. Opioid peptides (1 mM) were dissolved in 1 mM acetic acid, allquoted and stored at -80°C. Fresh dilutions of opioid peptides were prepared daily. Sources of other chemicals have been described elsewhere (Seifert et al. 1986; Seifert and Schultz 1987a, b; Seifert and Sch/ichtele 1988) .
Isolation of neutrophils.
Human neutrophils were prepared according to the procedure of Markert et al. (1984) with modifications. Briefly, at 9 a.m. blood was obtained by venous puncture from eight healthy volunteers of either sex (age between 24 and 40 years) in a sitting position. The volunteers had taken breakfast and had taken no drugs for at least 3 weeks. Fourty milliliters of blood were drawn from the cubital vein under gentle suction, using a Butterfly-21 winged needle (Abott, Wiesbaden, FRG) and a 50 ml LuerLock injectomat-syringe (Fresenius, Bad Homburg, FRG) . Blood was anticoagulated with heparin (50 I.E./ml) and was supplemented with 10 ml of a solution consisting of 6% (by weight) Dextran T 500 and 140 mM NaC1. After gentle mixing, erythrocytes were allowed to settle down at 20°C for 45 rain. The turbid upper layer containing leukocytes was carefully removed with a polyethylene transfer pipette (Sarstedt, Ntimbrecht, FRG) and placed into a 50 ml Plastibrand polypropylene centrifuge tube (Brand, Werthelm, FRG) . Leukocytes were pelleted by centrifugation at 20°C for 12 rain at 100 × g. All other centrifugations were also performed in these tubes. Remaining erythrocytes were lyzed by suspending the cell pellet in 3 ml of distilled water at 4°C under gentle agitation. After 30 s, isotonicity was restored by adding 1 ml of a solution containing 0.6 M NaC1. Cells were pelleted by centrifugation at 20 ° C for 5 min at 250 × g. Cells were suspended in 10 ml of the buffer used for the determination of O; formation not supplemented with CaCI2. This suspension was carefully layered onto 10 ml of Ficoll-Hypaque. Neutrophils were sedimented by centrifugation at 20°C for 20 min at 250 × g. Sedimented neutrophils were suspended in 5 ml of the buffer described above and were pelleted by centrifugation at 20 ° C for 5 min at 250 × g. The resulting cell pellet (3.0-8.0 x 107 cells) was suspended in 1 ml of the buffer described above using an 1.5 ml Eppendorf reaction vessel (Eppendorf, Hamburg, FRG). Cells were kept at 4°C until used. Cell preparations consisted of more than 98 % viable neutrophils as judged by trypan blue dye exclusion and Pappenheim-stained smears. Experiments were carried out within 3 h after completion of isolation.
Cell culture. HL-60 cells were grown in suspension culture in RPMI-1640 medium supplemented with 10% (by volume) horse serum, 1% (by volume) non-essential amino acids, 2 mM L-glutamine, 50 U/ml penicillin and 50 ~g/ml streptomycin in a humidified atmosphere with 7% CO2 at 37°C. To induce differentiation, HL-60 cells were seeded at a density of 10 6 cells/ml and were cultured for 48 h with 0.2 mM dbcAMP or for 120 h with 160 mM dimethyl sulfoxide (Chaplinski and Niedel 1982; Seifert and Schultz 1987b; Seifert and Sch/ichtele 1988) . Pappenheim stains showed that the differentiated cells consisted of more than 95% myelocytes or cells beyond this stage. Cell viability was > 90% as judged by trypan blue dye exclusion. Cells were harvested by centrifugation at 20°C for 10 min at 250 ×g. Cells were resuspended at a density of 108 cells/ml in the buffer used for the determination of O2 formation not supplemented with CaC12. Until used, cells were stored at 4 ° C in 1.5 ml Eppendorf reaction vessels. Experiments were carried out within 90 rain after harvesting cells.
Assay for 02 generation. 02 formation was monitored at 550 nm by continuous measurement of ferricytochrome C reduction inhibitable by superoxide dismutase, using an Uvikon 810 dual beam spectrophotometer (Kontron, Eching, FRG) (Markert et al. 1984; Seifert and Sch/ichtele 1988) . Reactions were carried out in Sarstedt polystyrol halfmicro cuvettes without stirring the cells. Reaction mixtures (0.5 ml) contained 100 ~M ferricytochrome C and a buffer consisting of 138 mM NaC1, 6 mM KC1, 1 mM MgC12, 1 mM CaC12, 1 mM Na2HPO4, 5 mM NaHCO3, 5.5 mM glucose and 20 mM Hepes, pH 7.4. Cells (0.5-1.0 × 10 6 neutrophils or 2.5 x 10 6 HL-60 cells) were suspended in the solution described above and were preincubated for 3 rain in the absence of CB at 37°C. O~ formation was initiated by the addition of stimuli. Reference cuvettes contained all the components listed above plus 50 ~tg of superoxide dismutase. In some experiments, the course of O~-formation was monitored for periods of up to 1 h (see Fig. 2 ). In the experiments shown in Fig. 1 and Tables 2-4, the absolute amounts of O~ generated within an incubation period of 20 rain were calculated (Markert et al. 1984) . Within this time, the fMet-Leu-Phe-induced O~ formation both in the absence and presence of CB had ceased completely under the experimental conditions choosen. In the experiments shown in Table 1 , Vmax was calculated, as the PMA-induced O~ formation did not cease until the ferricytochrome C was completely reduced.
Results
Activation of 02 formation in human neutrophils by fMetLeu-Phe, PAF and various opioids was compared in the concentration range from 10 pM to 1 gM (Fig. 1) . In the absence of agonists, neutrophils did not generate 0~. At concentrations of up to 1 nM, fMet-Leu-Phe did not activate In the presence and absence of CB, fMet-Leu-Phe activated 02 formation with ECs0 values of 20 and 50 nM, respectively. Activation of 02 formation by fMet-Leu-Phe reached a plateau at a concentration of 100 nM. CB did not only enhance 02 formation induced by fMet-Leu-Phe at submaximally and maximally stimulatory concentrations, but CB also primed the cells to respond to non-stimulatory concentrations of the chemotactic peptide (3-10 nM). In comparison to fMet-Leu-Phe, PAF was a less potent and effective activator of 02 generation. As a possible subtype of neutrophil opioid receptors is unknown (Lopker et al. 1980) , we studied the effects of opioids with specificities for different receptor subtypes on O£ formation. Methionine enkephalin and/~-endorphin are g-and 6-receptor agonists. Morphine and DAGO are preferential g-agonists, and DADL is a selective 6-agonist. In addition, dynorphin is a selective ~c-agonist (Goldstein and James 1984; Zukin and Zukin 1984) . In contrast to fMet-Leu-Phe and PAF, opioids did not activate 02 formation at concentrations between 10 pM to 1 gM in the absence or presence of CB in experiments carried out with neutrophils of eight different donors. Repeated experiments performed at different times with neutrophils of the same donor gave similar results (data not shown). Time courses of 02 formation in neutrophils are shown in Fig. 2 . In the absence of CB, tMet-Leu-Phe (30 nM) and PAF (300 nM) reversibly activated 02 formation, which ceased after 7 rain and 30 s, respectively. In contrast, /~-endorphin at concentrations of 1 pM, I nM and 1 pM did not induce 02 formation at incubation times as long as I h. Similar results were obtained with DAGO, DADL and dynorphin (data not shown).
We investigated the possibility that opioids potentiate O2 formation. PAF at non-stimulatory and stimulatory Fig. 2 ). In contrast to PAF, ATP at a concentration of 100gM per se did not activate O2 formation but synergistically enhanced the effect of the chemotactic peptide to the same extent as did PAF at a concentration of 300 nM. In contrast to PAF and ATP, /~-endorphin at concentrations of 1 pM, i nM and I gM did not enhance fMet-Leu-Phe-induced 02 formation. Similar results were obtained with DAGO, DADL and dynorphin (data not shown).
In rat peritoneal macrophages, methionine enkephalin shows a biphasic effect on PMA-induced 02 formation (Foris et al. 1986 ). Therefore, we studied the interaction of methionine enkephalin with PMA in human neutrophils (Table 1 ). At concentrations of 1 pM, 1 nM and 1 gM, methionine enkephalin did neither enhance nor inhibit 02 formation induced by PMA at a maximally stimulatory concentration (100 ng/ml). In addition, PGEI did not affect PMAinduced 02 formation. In contrast, fMet-Leu-Phe at a concentration of 1 gM stimulated PMA-induced 02 formation by 30%.
Pretreatment of neutrophils with a non-stimulatory concentration of PMA potentiated 02 formation induced by fMet-Leu-Phe at an over-threshold stimulatory concentration (30 nM) ( Table 2 ). In contrast, PMA did not enhance the small activation of 02 formation induced by PAF. In addition, PMA did not induce responsiveness of cells to non-stimulatory concentrations of fMet-Leu-Phe, ATP and /~-endorphin. These data suggest that priming of Oy formation by PMA was specific for overthreshold stimulatory concentrations of fMet-Leu-Phe.
Inhibition of fMet-Leu-Phe-induced O~ formation by various agents was investigated (Table 3 ). Submaximal and 23.9 ± 0,6 31.0±3,1' 23.9 ± 0,8 ~ 24.5 ± 0,6 a 23.1 ± 1,6" 24.2 ± 0.5" PMA (100 ng/ml) and various agonists or solvent (control) were added simultaneously to reaction mixtures. Experiments were carried out in the absence of cytochalasin B. In the experiments shown in the Table, Vm,x of O2 formation was calculated, as O£ formation in the presence of PMA did not cease until the ferricytochrome C was completely reduced. In the absence of PMA, fMet-Leu-Phe (1 gM) induced the formation of 5.3 ± 1.6 nmoles of Of x 10 6 cells-1 x rain-1. Data shown represent the mean ± SEM of experiments performed with neutrophils of five different donors. The statistical significance of the effects of fMet-Leu-Phe, methionine enkephaline and PGE1 versus the control was assessed using the Wilcoxon test: "not significant; * p < 0.05 Table 3 . Effect of morphine, enkephalin, naloxone, PGEI and Boc-PLPLP on fMet-Leu-Phe-induced O~-formation in human neutrophils Addition 0~-formation (nmol x 10 6 cells-1)
-CB + CB None 12.3 ± 1.5 32.5 + 3.0 Morphine (10 p-M)
11.7 ± 1.9" 31.9 ± 2.0" Methionine enkephaline (10 p-M) 12.1 ± 1.5 a 30.8 ± 1.6" Naloxone (10 ~tM) 11.7 ± 1.8" 30.2 ± 1.5 a PGE1 (10 p-M) 0.2 ± 0.1 * 0.6 ± 0.2* Boc-PLPLP (10 p.M) 0 b 0.5 + 0.3 * 3 min prior to the addition of fMet-Leu-Phe, various agents at the indicated concentrations or solvent (control) were added to reaction mixtures in the absence or presence of cytochalasin B (CB) (1 p-g/ ml). The absolute amounts of 02 generated within an incubation period of 20 min were calculated. Data shown represent the mean ± SEM of experiments carried out with neutrophils of six different donors. The statistical significance of the effect of morphine, methion±he enkephalin, naloxone, PGE1 and Boc-PLPLP versus control was assessed using the Wilcoxon test: a not significant; * p < 0.02 Table 2 . Effect of priming with PMA on O~ formation in human neutrophils Human neutrophils were treated with a non-stimulatory concentration of PMA (2 ng/ml) or solvent (control) for 3 min. Thereafter, stimuli were added to reaction mixtures. Experiments were carried out in the absence of cytochalasin B. The absolute amounts of 02 generated within an incubation period of 20 rain were calculated. Data shown represent the mean ± SEM of experiments carried out with neutrophils of five different donors. The statistical significance of the effect of priming with PMA was assessed using the Wilcoxon test: a not significant; * p < 0.05 maximal activation o f O f formation was achieved by omitting and adding CB to reaction mixtures, respectively. PGE1 strongly inhibited chemotactic peptide-induced activation of O ; formation in the presence and absence of CB. In addition, the competitive antagonist of fMet-Leu-Phe, Boc-PLPLP (Jesaitis et al. 1986 ), almost completely prevented activation of 0 2 formation by fMet-Leu-Phe. In contrast, morphine, methionine enkephalin and naloxone at a concentration as high as 10 gM did not inhibit 0 2 formation, regardless o f whether CB was present or not. The preincubat±on of neutrophils with naloxone for 30 min was also without inhibitory effect on fMet-Leu-Phe-induced 0 2 formation (data not shown). Finally, we investigated the possibility that opioids activated 0 2 formation in HL-60 cells. D b c A M P -and dimethyl sulfoxide-differentiated HL-60 cells generated substantial amounts of 0 2 upon stimulation with fMet-Leu-Phe 
fMet-Leu-Phe (1 gM) 19.2 ± 4.6 12.1 ± 2.6 PAF (1 gM) 3.0 ± 0.5 0 ATP (100 JiM) 7.7 ± 1.1 0 fl-Endorphin (1 pM, 1 nM, 1 p-M) 0 0 HL-60 cells were differentiated along the myeloid pathway with dibutyryl cAMP (dbcAMP) or dimethyl sulfoxide (Me2SO). O~ formation in differentiated HL-60 cells was measured in the presence of cytochalasin B (CB) (1 gg/ml). The absolute amounts of O; generated within an incubation period of 20 min were calculated. Data shown represent the mean ± SEM of experiments performed with three to five with different batches of cells (Table 4 ). In dbcAMP-differentiated HL-60 cells, P A F and ATP induced 0 2 formation to extents amounting to 16% and 40%, respectively, of that induced by fMet-Leu-Phe. P A F and ATP per se did not activate 0 2 formation in dimethyl sulfoxide-differentiated HL-60 cells. In contrast to P A F and ATP, fl-endorphin did not activate 0 2 formation in dbcAMP-differentiated HL-60 cells. These agents were also inactive in dimethyl sulfoxide-differentiated cells. D A G O , D A D L and dynorphin also failed to induce 0 2 formation in differentiated HL-60 cells (data not shown).
D i s c u s s i o n
The conflicting reports concerning the regulation of 0 2 formation by opioids prompted us to re-investigate this problem. We compared the effects of opioids with those of other well-known modulators of O~ formation under precisely defined experimental conditions. As far as activation of O2 formation by fMet-Leu-Phe, PAF and PMA is concerned, our results are in agreement with previously published work Baggiolini 1985, 1986; Rossi 1986) . This is also the case for potentiation of fMet-LeuPhe-induced 02 formation by CB, PAF and ATP (Dewald and Baggiolini 1985; Jesaitis et al. 1986; Kuhns et al. 1988) and for inhibition of 02 formation by Boc-PLPLP and PGE1 (Lad et al. 1985; Jesaitis et al. 1986 ). In addition, we confirmed that fMet-Leu-Phe enhanced PMA-induced activation of 02 formation and that PMA at nonstimulatory concentrations potentiated the effect of fMetLeu-Phe (Bender et al. 1987; Ohsaka et al. 1988; Raj Tyagi et al. 1988) . In contrast to other recent studies (Sharp et al. 1985 (Sharp et al. , 1987 Simpkins et al. 1985 Simpkins et al. , 1986 Foris et al. 1986 Foris et al. , 1987 Nagy et al. 1988 ), we did not find any stimulatory or inhibitory effect of a broad spectrum of opioids on O~-formation under different experimental conditions. In the studies cited above, regulation of 02 formation by opioids, fMet-LeuPhe and PMA showed some interesting features. At concentrations of up to 10 nM, opioid peptides and morphine stimulated O2 formation, whereas these agents at higher concentrations were less effective (Sharp et al. 1985; Nagy et al. 1988) . These biphasic concentration response functions to opioids are anomalous and are in contrast to the sigmoid concentration response functions found for many other classes of agonists which activate O2 formation (see Fig. 1 ; Bender et al. 1987; Ohsaka et al. 1988; Sibinga and Goldstein 1988) . However, Sibinga and Goldstein (1988) have pointed out that a biphasic concentration response function may point to the presence of multiple receptors mediating opposite effects. At concentrations of 1-100 nM, methionine enkephalin enhanced PMA-induced O~-formation in macrophages, whereas at higher concentrations it inhibited 02 formation (Foris et al. 1986 ). In neutrophils, PMAinduced 02 formation is resistent to inhibition by receptor agonists such as PGE1 (see Table 1 ; Penfield and Dale 1985) . In addition, the experiments reported in the studies of Simpkins et al. (1985 Simpkins et al. ( , 1986 , Sharp et al. (1985 Sharp et al. ( , 1987 , Foris et al. (1986) and Nagy et al. (1988) were carried out in the absence of CB. These authors observed long-lasting activations of 02 formation by opioids and fMet-Leu-Phe. Furthermore, Simpkins et al. (1986) and Nagy et al. (1988) observed basal release of 02 from neutrophils in the absence of agonists. In contrast, we and others found that, in the absence of CB, chemotactic peptides induce only a brief activation of 02 formation and that neutrophils do not generate 02 in the absence of agonists (see Fig. 2 ; Dewald and Baggiolini 1985; Jesaitis et al. 1986 ). Sharp et al. (1987) reported that fMet-Leu-Phe stimulated O£ formation in the absence of CB at a concentration as low as 0.1 nM, i.e. a concentration much lower than that required for activation O2 formation in our present study and in other studies (see Fig. 1 ; Dewald and Baggiolini 1986; Kuhns et al. 1988; Ohsaka et al. 1988) . Nagy et al. (1988) reported that activation of 02 formation by fMet-Leu-Phe was maximal at a concentration of 1 nM, whereas fMet-Leu-Phe at concentrations above 10 nM was much less effective. These results are also not in agreement with the results of the present study and other publications (see Fig. 1 ; Dewald and Baggiolini 1986; Kuhns et al. 1988; Ohsaka et al. 1988) .
All these data show that the effects of fMet-Leu-Phe, PMA, PAF, ATP, CB and PGE1 but not of opioids on 02 formation in human neutrophils are reproducible. Thus, how can these discrepancies be explained? It has been pointed out that the cells used in the above cited studies on opioid modulation of O2 formation showed some unusual properties which may be essential to demonstrate effects of opioids on this effector system. The identity of these factors may be complex. First, it is known that unknown factors of human serum modulate the responses of neutrophils and monocytes in vitro to a variety of intercellular signal molecules (Hashimoto et al. 1982; Berkow et al. 1984; Motulsky et al. 1987) . Second, activation of 02 formation in vitro is affected by a number of factors during cell isolation such as temperature, centrifugal forces, presence of serum, dextran, Ficoll-Hypaque and buffer constituents (Berkow et al. 1984; English et al. 1988 ). Third, the storage time and storage conditions after cell isolation influence O2 formation (English et al. 1981 (English et al. , 1988 Dahlgren et al. 1987 ). In addition, the time of contact with a stimulus may be an important factor (English et al. 1988) . Furthermore, the assay conditions during the measurement of O2 are of great importance. For example, it has been shown that the quantity and kinetics of 02 formation induced by a variety of stimuli including chemotactic peptides and cytokines are substantially altered by cell surface contact (Dahinden et al. 1983; Nathan 1987) . Thus, the differences between the results of our present study and of other studies concerning the comparison of the effects of opioids and chemotactic peptides on 02 formation in human neutrophils may be explained, at least in part, by differences in the experimental design. However, published studies on modulation of O2 formation by opioids did not define these potentially important factors and did not provide sufficiently detailed information on the experimental procedures to identify one of these factors.
In conclusion, we did not find any evidence for a role of opioids in the regulation of 02 formation. Possibly, regulation of 02 formation by opioids is more sensitive to the experimental conditions used than the one by other wellestablished intercellular signal molecules. Future studies dealing with this problem have to exactly describe the experimental procedures in order to define the conditions under which opioids either stimulate or inhibit O2 formation. In addition, the comparison of the effects of opioids with other intercellular signal molecules is essential to properly assess these studies.
